Cataracts, a common eye condition, can be best described as when you’re wearing ‘reading glasses’ that become a bit blurry, akin to looking through fog. To date, surgery remains the only treatment method, whereby the blurred ‘reading glasses’ are replaced with a new artificial lens, restoring visual acuity. I’ve been asked, are there any eye drops that can treat cataracts?
As of this writing, no eye drops have been approved by the U.S. Food and Drug Administration (FDA) to treat cataract. However, scientists are working hard on research.
A study published in 2015 discovered that a substance called lanosterol could reverse the protein aggregation in cataracts, opening up new possibilities for prevention and treatment of this condition.  Trusted Website PubMed is a data base from US National Institutes of Health. It’s a trusted source of health and medical information. Open the link → However, due to lanosterol’s limited solubility, scientists must inject it directly into the eye to be effective, so it can’t be made into eye drops just yet.
Back in 2008, a U.S. company conducted clinical trials for their ‘cataract eye drops’ called C-KAD. Unfortunately, there hasn’t been any promising news since then. 
Until eye drops become a reliable choice for cataract treatment, if you’re diagnosed with cataracts, consult a certified ophthalmologist to discuss surgical treatment. If surgery isn’t an option and you want to try eye drops anyway, you may consider Can-C.
Can-C contains a substance called N-Acetylcarnosine (NAC), mainly used in ophthalmology as an antioxidant. Cataracts primarily result from oxidation and coagulation of proteins in the eye lens, causing blurred vision. NAC eye drops are thought to potentially slow or prevent this protein oxidation and coagulation through their antioxidant effect, thus helping to maintain or improve vision.
In 2004, Russian ophthalmologist Mark Babizhayev conducted a small-scale trial and found that N-Acetylcarnosine improved the clarity of vision in cataract patients: “These data showed that N-acetylcarnosine is effective in the management of age-related cataract reversal and prevention both in human and in canine eyes.”  Trusted Website PubMed is a data base from US National Institutes of Health. It’s a trusted source of health and medical information. Open the link →
Many people have purchased Can-C in hope to alleviate or treat their cataracts. For instance, we see this customer review:
“Being a non-surgical oriented person, I began researching non-surgical cataract treatments… although I was very skeptical that anything but surgery would correct the cataracts. I came across Can-C and read the research by the original Russian scientist and ordered a five-month supply. After just 1-week, I noticed more vivid colors and both cataracts appeared to be smaller. Fast forward to almost 3-months usage … and I’m blown-away with the fantastic results. Not only can I read fine print … both cataracts have shrunk in size by about 80%… truly unbelievable!”
Another eye drop containing NAC is Oclumed Nutritional Eye Drops.
OcluMed eye drops’ ingredients include amino acids, NAC, and nutrients. The manufacturer claims it helps to repair and maintain damaged proteins, clear cloudiness, and rejuvenate vision.
Let’s reiterate: no eye drops have yet been approved by the FDA for treating cataracts. Surgery is still the only reliable treatment method. If you, or someone you know, is diagnosed with cataracts, it’s advised to consult an ophthalmologist for professional guidance.
. Zhao L, Chen XJ, Zhu J, Xi YB, Yang X, Hu LD, Ouyang H, Patel SH, Jin X, Lin D, Wu F, Flagg K, Cai H, Li G, Cao G, Lin Y, Chen D, Wen C, Chung C, Wang Y, Qiu A, Yeh E, Wang W, Hu X, Grob S, Abagyan R, Su Z, Tjondro HC, Zhao XJ, Luo H, Hou R, Jefferson J, Perry P, Gao W, Kozak I, Granet D, Li Y, Sun X, Wang J, Zhang L, Liu Y, Yan YB, Zhang K. Lanosterol reverses protein aggregation in cataracts. Nature. 2015 Jul 30;523(7562):607-11. doi: 10.1038/nature14650. Epub 2015 Jul 22. Erratum in: Nature. 2015 Oct 22;526(7574):595. PMID: 26200341.
. Babizhayev MA, Deyev AI, Yermakova VN, Brikman IV, Bours J. Lipid peroxidation and cataracts: N-acetylcarnosine as a therapeutic tool to manage age-related cataracts in human and in canine eyes. Drugs R D. 2004;5(3):125-39. doi: 10.2165/00126839-200405030-00001. PMID: 15139774.
Disclosure: We are an Amazon Associate. Some links on this website are affiliate links, which means we may earn a commission or receive a referral fee when you sign up or make a purchase through those links.